Israel escalates military action in Gaza, violates ceasefire amid rising casualties    Egypt reviews plans for first national medical simulation centre    GAFI unveils updated framework for financial valuation, due diligence    Al-Sisi, Haftar discuss Libya stability, call for withdrawal of foreign forces    EgyptAnode ships first export batch since restart: Public Enterprises Ministry    Gold prices in Egypt rise on Monday, 08 Dec., 2025    EBRD, National Bank of Egypt sign $100m facility to support small businesses    Egyptian pound nudges higher in early Monday trade    GREEN DOCK 3 successfully transits Suez Canal in 24-hour operation    Egypt, Qatar press for full implementation of Gaza ceasefire    Egypt calls for inclusive Nile Basin dialogue, warns against 'hostile rhetoric'    Egypt, China's CMEC sign MoU to study waste-to-energy project in Qalyubia    Egypt joins Japan-backed UHC Knowledge Hub to advance national health reforms    Egypt launches 32nd International Quran Competition with participants from over 70 countries    Al-Sisi reviews expansion of Japanese school model in Egypt    Egypt declares Red Sea's Great Coral Reef a new marine protected area    Egypt recovers two ancient artefacts from Belgium    Egypt, Saudi nuclear authorities sign MoU to boost cooperation on nuclear safety    Giza master plan targets major hotel expansion to match Grand Egyptian Museum launch    Australia returns 17 rare ancient Egyptian artefacts    China invites Egypt to join African duty-free export scheme    Egypt calls for stronger Africa-Europe partnership at Luanda summit    Egypt begins 2nd round of parliamentary elections with 34.6m eligible voters    Egypt warns of erratic Ethiopian dam operations after sharp swings in Blue Nile flows    Egypt scraps parliamentary election results in 19 districts over violations    Egypt extends Ramses II Tokyo Exhibition as it draws 350k visitors to date    Filmmakers, experts to discuss teen mental health at Cairo festival panel    Cairo International Film Festival to premiere 'Malaga Alley,' honour Khaled El Nabawy    Egypt golf team reclaims Arab standing with silver; Omar Hisham Talaat congratulates team    Egypt launches Red Sea Open to boost tourism, international profile    Omar Hisham Talaat: Media partnership with 'On Sports' key to promoting Egyptian golf tourism    Sisi expands national support fund to include diplomats who died on duty    Egypt's PM reviews efforts to remove Nile River encroachments    Egypt resolves dispute between top African sports bodies ahead of 2027 African Games    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Russia says it's in sync with US, China, Pakistan on Taliban    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Egypt's Sisi wants 1mn Hepatitis C doses from drug companies
Egypt's President Abdel-Fattah El-Sisi addressed "virus C drug companies" asking them to reduce their prices for Egyptians, already at one percent of original cost
Published in Ahram Online on 12 - 05 - 2015

Egypt's President Abdel-Fattah El-Sisi proposed on Tuesday a new deal to buy one million doses of treatment annually from "virus C drug companies" at a reduced price to treat the disease that is endemic in the country.
Last year, Egypt's health ministry brokered a deal with US biopharmaceutical company Gilead Sciences to import a drug, commercially known as Sovaldi, to cure hepatitis C at a cost of $900, down from its cost in the US of $84,000 for a three-month treatment.
Some 15 million Egyptians, 22 per cent of the population, suffer from Hepatitis C - the highest prevalence of the virus in the world - according to the World Health Organization.
El-Sisi, in a televised monthly speech, said the deal with the companies would be in addition to the already existing agreement with the health ministry.
The president said that if the deal is brokered, the highest proportion of the drugs would go to youth suffering from the virus.
Egypt's government devised an online registration system for patients to register for the treatment. Priority has been given to those with higher levels of liver deterioration.
http://english.ahram.org.eg/News/130095.aspx


Clic here to read the story from its source.